Journal of Biological Regulators and Homeostatic Agents 2019-Mar-Apr,

Broser® (bromelain, escin and selenium), oral nutraceutical, monotherapy in patients with inflammatory otorhinolaryngological disorders.

Only registered users can translate articles

The link is saved to the clipboard

G Cupido

M Gelardi

I La Mantia

S Aragona

G Ciprandi

Italian Study Group on Inflammatory Otorhinolaryngological Disorders. Aielli Federica, Albanese Gianluca, Allosso Giuseppe, Amadori Maurizio, Antoniacomi Giovanni, Asprea Francesco, Auletta Pasquale, Azzaro Raffaele, Balduzzi Attilio, Bellini Vito, Benedetto Domenico, Berardi Carlo, Bernardi Rosanna, Bianchi Alessandro, Bordonaro Carla, Brindisi Annamaria, Buccolieri Marcello, Bulzomì Antonio Giovanni, Caligo Giacomo, Cantaffa Antonio, Carboni Sebastiano, Cascio Felice, Cassano Michele, Castagna Giovanni, Castellani Francesca, Chillura Mario, Colombo Giovanni, Corbetta Marco, Cordier Aldo, Costanzo Marcello, Cupido Francesco, Cupido Gianfranco, Danza Carlo, De Luca Carlo, Di Maria Domenico, Falcetti Saverio, Falciglia Roberto, Ferraro Guglielmo, Forte Sebastiano, Franco Teresa, Franzetti Andrea, Frisina Antonio, Gambardella Giuseppe, Gambardella Tullio, Iannello Franco, Ierace Michelangelo, Ingria Federico, La Mantia Ignazio, La Paglia Alessandro, Leone Mirko, Lingua Cristiano, Lovotti Paolo, Machetta Giacomo, Maddalena Gianluca, Maffezzoni Enrico, Mangiatordi Francesco Gerardo, Maniscalco Francesco, Melis Andrea, Mercurio Antonio, Milone Vincenzo, Mirra Nicola, Montanaro Salvatore Carmine, Moro Davide, Muià Fernando, Mussella Tommaso, Nacci Andrea, Padovani Davide, Panetti Maria Luisa, Paoletti Matteo, Piccolo Marcello, Pizzolante Maurizio Cosimo, Principi Pietro, Sari Marianna, Scarpa Alfonso, Serraino Eugenio Maurizio, Stabile Carlo, Tomacelli Giovanni, Tombolini Alberto, Trichini Antonio Fabio, Vergari Alessandro, Zaraca Giorgio

ARTICLE: 30891997

BioSeek: 30891997

Keywords

inflammation

bromelain

escin

anti inflammatory

Abstract

Inflammation is a common pathogenic mechanism involved in many otorhinolaryngological (ORL) disorders. Broser® is an oral nutraceutical currently containing bromelain 100 mg, escin 30 mg, and selenium 42.5 mcg. It could exert a safe and effective anti-inflammatory activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients.